These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors. Buza A; Türkeş C; Arslan M; Demir Y; Dincer B; Nixha AR; Beydemir Ş Int J Biol Macromol; 2023 Jun; 239():124232. PubMed ID: 37001773 [TBL] [Abstract][Full Text] [Related]
3. In-vitro and in-silico investigations of SLC-0111 hydrazinyl analogs as human carbonic anhydrase I, II, IX, and XII inhibitors. Sharma V; Vats L; Giovannuzzi S; Mohan B; Supuran CT; Sharma PK Arch Pharm (Weinheim); 2024 Aug; 357(8):e2400157. PubMed ID: 38713910 [TBL] [Abstract][Full Text] [Related]
7. Continued exploration and tail approach synthesis of benzenesulfonamides containing triazole and dual triazole moieties as carbonic anhydrase I, II, IV and IX inhibitors. Vats L; Kumar R; Bua S; Nocentini A; Gratteri P; Supuran CT; Sharma PK Eur J Med Chem; 2019 Dec; 183():111698. PubMed ID: 31539777 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors. Said MA; Eldehna WM; Nocentini A; Bonardi A; Fahim SH; Bua S; Soliman DH; Abdel-Aziz HA; Gratteri P; Abou-Seri SM; Supuran CT Eur J Med Chem; 2020 Jan; 185():111843. PubMed ID: 31718943 [TBL] [Abstract][Full Text] [Related]
14. Benzenesulfonamide bearing 1,2,4-triazole scaffolds as potent inhibitors of tumor associated carbonic anhydrase isoforms hCA IX and hCA XII. SitaRam ; Celik G; Khloya P; Vullo D; Supuran CT; Sharma PK Bioorg Med Chem; 2014 Mar; 22(6):1873-82. PubMed ID: 24560737 [TBL] [Abstract][Full Text] [Related]
15. S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors. El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Alanazi MM; El-Gendy MA; Ahmed HEA; Supuran CT J Enzyme Inhib Med Chem; 2020 Dec; 35(1):733-743. PubMed ID: 32189526 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and in silico insights of novel 1,2,3-triazole benzenesulfonamide derivatives as potential carbonic anhydrase IX and XII inhibitors with promising anticancer activity. Abdelhakeem MM; Morcoss MM; Hanna DA; Lamie PF Bioorg Chem; 2024 Mar; 144():107154. PubMed ID: 38309003 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of a new series of N⁴-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII. Sławiński J; Brzozowski Z; Żołnowska B; Szafrański K; Pogorzelska A; Vullo D; Supuran CT Eur J Med Chem; 2014 Sep; 84():59-67. PubMed ID: 25016228 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of novel benzenesulfonamide bearing 1,2,3-triazole linked hydroxy-trifluoromethylpyrazolines and hydrazones as selective carbonic anhydrase isoforms IX and XII inhibitors. Sharma V; Kumar R; Bua S; Supuran CT; Sharma PK Bioorg Chem; 2019 Apr; 85():198-208. PubMed ID: 30622012 [TBL] [Abstract][Full Text] [Related]